nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxsalen—vitiligo—skin cancer	0.543	0.806	CtDrD
Methoxsalen—psoriasis—skin cancer	0.131	0.194	CtDrD
Methoxsalen—CYP1A2—Imiquimod—skin cancer	0.0432	0.179	CbGbCtD
Methoxsalen—CYP1A1—Dacarbazine—skin cancer	0.0406	0.168	CbGbCtD
Methoxsalen—CYP2A6—Fluorouracil—skin cancer	0.0278	0.115	CbGbCtD
Methoxsalen—CYP2A13—nose—skin cancer	0.0258	0.869	CbGeAlD
Methoxsalen—CYP1A2—Vemurafenib—skin cancer	0.0237	0.0979	CbGbCtD
Methoxsalen—CYP3A4—Imiquimod—skin cancer	0.0226	0.0936	CbGbCtD
Methoxsalen—CYP3A4—Temozolomide—skin cancer	0.0226	0.0936	CbGbCtD
Methoxsalen—CYP1A2—Dacarbazine—skin cancer	0.0181	0.075	CbGbCtD
Methoxsalen—CYP3A4—Vismodegib—skin cancer	0.0157	0.0649	CbGbCtD
Methoxsalen—CYP3A4—Vemurafenib—skin cancer	0.0124	0.0513	CbGbCtD
Methoxsalen—CYP1A2—Fluorouracil—skin cancer	0.0106	0.044	CbGbCtD
Methoxsalen—CYP3A4—Docetaxel—skin cancer	0.00425	0.0176	CbGbCtD
Methoxsalen—Sunburn—Vemurafenib—skin cancer	0.00295	0.0536	CcSEcCtD
Methoxsalen—Device related infection—Fluorouracil—skin cancer	0.00242	0.0439	CcSEcCtD
Methoxsalen—Pain of skin—Bleomycin—skin cancer	0.00229	0.0416	CcSEcCtD
Methoxsalen—Leukoderma—Imiquimod—skin cancer	0.00179	0.0325	CcSEcCtD
Methoxsalen—Folliculitis—Vemurafenib—skin cancer	0.00142	0.0258	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Imiquimod—skin cancer	0.00128	0.0232	CcSEcCtD
Methoxsalen—Folliculitis—Imiquimod—skin cancer	0.00121	0.022	CcSEcCtD
Methoxsalen—CYP1A1—skin epidermis—skin cancer	0.00106	0.0358	CbGeAlD
Methoxsalen—Skin hyperpigmentation—Bleomycin—skin cancer	0.000907	0.0165	CcSEcCtD
Methoxsalen—Tenderness—Imiquimod—skin cancer	0.00087	0.0158	CcSEcCtD
Methoxsalen—Herpes simplex—Imiquimod—skin cancer	0.000824	0.015	CcSEcCtD
Methoxsalen—Lupus erythematosus—Docetaxel—skin cancer	0.000812	0.0148	CcSEcCtD
Methoxsalen—Folliculitis—Dactinomycin—skin cancer	0.0008	0.0146	CcSEcCtD
Methoxsalen—Inflammation—Imiquimod—skin cancer	0.000783	0.0142	CcSEcCtD
Methoxsalen—Skin exfoliation—Imiquimod—skin cancer	0.000725	0.0132	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Fluorouracil—skin cancer	0.000705	0.0128	CcSEcCtD
Methoxsalen—Digestion impaired—Temozolomide—skin cancer	0.000681	0.0124	CcSEcCtD
Methoxsalen—Tenderness—Bleomycin—skin cancer	0.000618	0.0112	CcSEcCtD
Methoxsalen—Dysgeusia—Vismodegib—skin cancer	0.000617	0.0112	CcSEcCtD
Methoxsalen—Muscle spasms—Vismodegib—skin cancer	0.000606	0.011	CcSEcCtD
Methoxsalen—Dry skin—Vemurafenib—skin cancer	0.000592	0.0108	CcSEcCtD
Methoxsalen—Blister—Fluorouracil—skin cancer	0.000582	0.0106	CcSEcCtD
Methoxsalen—Systemic lupus erythematosus—Docetaxel—skin cancer	0.000546	0.00994	CcSEcCtD
Methoxsalen—CYP1A2—nipple—skin cancer	0.000521	0.0176	CbGeAlD
Methoxsalen—Skin exfoliation—Bleomycin—skin cancer	0.000515	0.00936	CcSEcCtD
Methoxsalen—CYP1A1—nipple—skin cancer	0.000514	0.0173	CbGeAlD
Methoxsalen—Photosensitivity reaction—Vemurafenib—skin cancer	0.00051	0.00927	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Docetaxel—skin cancer	0.000509	0.00925	CcSEcCtD
Methoxsalen—Skin disorder—Vismodegib—skin cancer	0.000499	0.00908	CcSEcCtD
Methoxsalen—Herpes simplex—Temozolomide—skin cancer	0.000494	0.00898	CcSEcCtD
Methoxsalen—Tenderness—Fluorouracil—skin cancer	0.00048	0.00874	CcSEcCtD
Methoxsalen—Herpes simplex—Fluorouracil—skin cancer	0.000455	0.00827	CcSEcCtD
Methoxsalen—Dyspepsia—Vismodegib—skin cancer	0.000452	0.00823	CcSEcCtD
Methoxsalen—Redness—Docetaxel—skin cancer	0.000448	0.00815	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Vismodegib—skin cancer	0.000444	0.00807	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Imiquimod—skin cancer	0.000435	0.00791	CcSEcCtD
Methoxsalen—Skin exfoliation—Temozolomide—skin cancer	0.000434	0.0079	CcSEcCtD
Methoxsalen—Inflammation—Fluorouracil—skin cancer	0.000432	0.00786	CcSEcCtD
Methoxsalen—Depression—Imiquimod—skin cancer	0.000423	0.0077	CcSEcCtD
Methoxsalen—Erythema—Vemurafenib—skin cancer	0.000389	0.00708	CcSEcCtD
Methoxsalen—Dysgeusia—Vemurafenib—skin cancer	0.000381	0.00693	CcSEcCtD
Methoxsalen—Pruritus—Vismodegib—skin cancer	0.000364	0.00661	CcSEcCtD
Methoxsalen—CYP1A1—epithelium—skin cancer	0.000346	0.0117	CbGeAlD
Methoxsalen—Arrhythmia—Imiquimod—skin cancer	0.000341	0.00619	CcSEcCtD
Methoxsalen—Erythema—Imiquimod—skin cancer	0.000332	0.00603	CcSEcCtD
Methoxsalen—CYP1A1—skin of body—skin cancer	0.000329	0.0111	CbGeAlD
Methoxsalen—Rash—Vismodegib—skin cancer	0.000324	0.00589	CcSEcCtD
Methoxsalen—Dermatitis—Vismodegib—skin cancer	0.000324	0.00589	CcSEcCtD
Methoxsalen—Dermatitis bullous—Fluorouracil—skin cancer	0.000318	0.00579	CcSEcCtD
Methoxsalen—Infection—Vemurafenib—skin cancer	0.000316	0.00574	CcSEcCtD
Methoxsalen—Inflammation—Docetaxel—skin cancer	0.000312	0.00567	CcSEcCtD
Methoxsalen—Skin disorder—Vemurafenib—skin cancer	0.000308	0.00561	CcSEcCtD
Methoxsalen—Ill-defined disorder—Imiquimod—skin cancer	0.000308	0.0056	CcSEcCtD
Methoxsalen—Nausea—Vismodegib—skin cancer	0.000305	0.00555	CcSEcCtD
Methoxsalen—Dry skin—Temozolomide—skin cancer	0.000303	0.0055	CcSEcCtD
Methoxsalen—CYP1A1—mammalian vulva—skin cancer	0.0003	0.0101	CbGeAlD
Methoxsalen—Malaise—Imiquimod—skin cancer	0.000299	0.00544	CcSEcCtD
Methoxsalen—Hypotension—Vemurafenib—skin cancer	0.000297	0.0054	CcSEcCtD
Methoxsalen—Skin exfoliation—Docetaxel—skin cancer	0.000289	0.00525	CcSEcCtD
Methoxsalen—Discomfort—Imiquimod—skin cancer	0.000279	0.00508	CcSEcCtD
Methoxsalen—Dry skin—Fluorouracil—skin cancer	0.000279	0.00507	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000274	0.00499	CcSEcCtD
Methoxsalen—Oedema—Imiquimod—skin cancer	0.000271	0.00493	CcSEcCtD
Methoxsalen—Infection—Imiquimod—skin cancer	0.000269	0.00489	CcSEcCtD
Methoxsalen—Skin disorder—Imiquimod—skin cancer	0.000263	0.00478	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Temozolomide—skin cancer	0.000261	0.00474	CcSEcCtD
Methoxsalen—CYP1A1—female reproductive system—skin cancer	0.000257	0.00866	CbGeAlD
Methoxsalen—Depression—Temozolomide—skin cancer	0.000254	0.00461	CcSEcCtD
Methoxsalen—Body temperature increased—Vemurafenib—skin cancer	0.000251	0.00457	CcSEcCtD
Methoxsalen—Insomnia—Imiquimod—skin cancer	0.000245	0.00445	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Fluorouracil—skin cancer	0.00024	0.00437	CcSEcCtD
Methoxsalen—Dyspepsia—Imiquimod—skin cancer	0.000238	0.00434	CcSEcCtD
Methoxsalen—Erythema—Bleomycin—skin cancer	0.000236	0.00429	CcSEcCtD
Methoxsalen—Hypersensitivity—Vemurafenib—skin cancer	0.000234	0.00425	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Imiquimod—skin cancer	0.000234	0.00425	CcSEcCtD
Methoxsalen—Dermatitis bullous—Docetaxel—skin cancer	0.00023	0.00418	CcSEcCtD
Methoxsalen—Pruritus—Vemurafenib—skin cancer	0.000225	0.00409	CcSEcCtD
Methoxsalen—Feeling abnormal—Imiquimod—skin cancer	0.000223	0.00406	CcSEcCtD
Methoxsalen—Erythema—Dactinomycin—skin cancer	0.00022	0.004	CcSEcCtD
Methoxsalen—Ill-defined disorder—Bleomycin—skin cancer	0.000219	0.00398	CcSEcCtD
Methoxsalen—Urticaria—Imiquimod—skin cancer	0.000215	0.00391	CcSEcCtD
Methoxsalen—CYP1A1—head—skin cancer	0.000215	0.00724	CbGeAlD
Methoxsalen—Body temperature increased—Imiquimod—skin cancer	0.000214	0.00389	CcSEcCtD
Methoxsalen—Malaise—Bleomycin—skin cancer	0.000213	0.00387	CcSEcCtD
Methoxsalen—Dizziness—Vemurafenib—skin cancer	0.00021	0.00382	CcSEcCtD
Methoxsalen—Ill-defined disorder—Dactinomycin—skin cancer	0.000204	0.00371	CcSEcCtD
Methoxsalen—Dry skin—Docetaxel—skin cancer	0.000201	0.00366	CcSEcCtD
Methoxsalen—Rash—Vemurafenib—skin cancer	0.0002	0.00364	CcSEcCtD
Methoxsalen—Dermatitis—Vemurafenib—skin cancer	0.0002	0.00364	CcSEcCtD
Methoxsalen—Hypersensitivity—Imiquimod—skin cancer	0.0002	0.00363	CcSEcCtD
Methoxsalen—Headache—Vemurafenib—skin cancer	0.000199	0.00362	CcSEcCtD
Methoxsalen—Erythema—Temozolomide—skin cancer	0.000199	0.00362	CcSEcCtD
Methoxsalen—Discomfort—Bleomycin—skin cancer	0.000198	0.00361	CcSEcCtD
Methoxsalen—Malaise—Dactinomycin—skin cancer	0.000198	0.00361	CcSEcCtD
Methoxsalen—Dysgeusia—Temozolomide—skin cancer	0.000195	0.00354	CcSEcCtD
Methoxsalen—Oedema—Bleomycin—skin cancer	0.000192	0.0035	CcSEcCtD
Methoxsalen—Pruritus—Imiquimod—skin cancer	0.000192	0.00348	CcSEcCtD
Methoxsalen—Infection—Bleomycin—skin cancer	0.000191	0.00348	CcSEcCtD
Methoxsalen—Nausea—Vemurafenib—skin cancer	0.000189	0.00343	CcSEcCtD
Methoxsalen—CYP3A4—female reproductive system—skin cancer	0.000189	0.00636	CbGeAlD
Methoxsalen—Arrhythmia—Fluorouracil—skin cancer	0.000188	0.00342	CcSEcCtD
Methoxsalen—Discomfort—Dactinomycin—skin cancer	0.000185	0.00336	CcSEcCtD
Methoxsalen—Ill-defined disorder—Temozolomide—skin cancer	0.000185	0.00336	CcSEcCtD
Methoxsalen—Erythema—Fluorouracil—skin cancer	0.000183	0.00333	CcSEcCtD
Methoxsalen—Hypotension—Bleomycin—skin cancer	0.00018	0.00327	CcSEcCtD
Methoxsalen—Oedema—Dactinomycin—skin cancer	0.000179	0.00326	CcSEcCtD
Methoxsalen—Malaise—Temozolomide—skin cancer	0.000179	0.00326	CcSEcCtD
Methoxsalen—Dizziness—Imiquimod—skin cancer	0.000179	0.00326	CcSEcCtD
Methoxsalen—Vertigo—Temozolomide—skin cancer	0.000179	0.00325	CcSEcCtD
Methoxsalen—Infection—Dactinomycin—skin cancer	0.000178	0.00324	CcSEcCtD
Methoxsalen—Rash—Imiquimod—skin cancer	0.000171	0.00311	CcSEcCtD
Methoxsalen—Dermatitis—Imiquimod—skin cancer	0.000171	0.0031	CcSEcCtD
Methoxsalen—Headache—Imiquimod—skin cancer	0.00017	0.00309	CcSEcCtD
Methoxsalen—Discomfort—Temozolomide—skin cancer	0.000167	0.00304	CcSEcCtD
Methoxsalen—Oedema—Temozolomide—skin cancer	0.000162	0.00295	CcSEcCtD
Methoxsalen—Infection—Temozolomide—skin cancer	0.000161	0.00293	CcSEcCtD
Methoxsalen—Nausea—Imiquimod—skin cancer	0.000161	0.00293	CcSEcCtD
Methoxsalen—Feeling abnormal—Bleomycin—skin cancer	0.000159	0.00288	CcSEcCtD
Methoxsalen—Skin disorder—Temozolomide—skin cancer	0.000158	0.00287	CcSEcCtD
Methoxsalen—Discomfort—Fluorouracil—skin cancer	0.000154	0.0028	CcSEcCtD
Methoxsalen—Urticaria—Bleomycin—skin cancer	0.000153	0.00278	CcSEcCtD
Methoxsalen—Body temperature increased—Bleomycin—skin cancer	0.000152	0.00277	CcSEcCtD
Methoxsalen—CYP1A1—lymph node—skin cancer	0.00015	0.00507	CbGeAlD
Methoxsalen—Oedema—Fluorouracil—skin cancer	0.00015	0.00272	CcSEcCtD
Methoxsalen—Infection—Fluorouracil—skin cancer	0.000149	0.0027	CcSEcCtD
Methoxsalen—Feeling abnormal—Dactinomycin—skin cancer	0.000148	0.00269	CcSEcCtD
Methoxsalen—Insomnia—Temozolomide—skin cancer	0.000147	0.00267	CcSEcCtD
Methoxsalen—Dyspepsia—Temozolomide—skin cancer	0.000143	0.0026	CcSEcCtD
Methoxsalen—Body temperature increased—Dactinomycin—skin cancer	0.000142	0.00258	CcSEcCtD
Methoxsalen—Hypersensitivity—Bleomycin—skin cancer	0.000142	0.00258	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Temozolomide—skin cancer	0.00014	0.00255	CcSEcCtD
Methoxsalen—Hypotension—Fluorouracil—skin cancer	0.00014	0.00254	CcSEcCtD
Methoxsalen—Pruritus—Bleomycin—skin cancer	0.000136	0.00248	CcSEcCtD
Methoxsalen—Arrhythmia—Docetaxel—skin cancer	0.000136	0.00247	CcSEcCtD
Methoxsalen—Insomnia—Fluorouracil—skin cancer	0.000135	0.00246	CcSEcCtD
Methoxsalen—Feeling abnormal—Temozolomide—skin cancer	0.000134	0.00243	CcSEcCtD
Methoxsalen—Erythema—Docetaxel—skin cancer	0.000132	0.0024	CcSEcCtD
Methoxsalen—Hypersensitivity—Dactinomycin—skin cancer	0.000132	0.0024	CcSEcCtD
Methoxsalen—Dyspepsia—Fluorouracil—skin cancer	0.000132	0.00239	CcSEcCtD
Methoxsalen—Dysgeusia—Docetaxel—skin cancer	0.00013	0.00236	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000129	0.00235	CcSEcCtD
Methoxsalen—Urticaria—Temozolomide—skin cancer	0.000129	0.00234	CcSEcCtD
Methoxsalen—Body temperature increased—Temozolomide—skin cancer	0.000128	0.00233	CcSEcCtD
Methoxsalen—Muscle spasms—Docetaxel—skin cancer	0.000127	0.00231	CcSEcCtD
Methoxsalen—Feeling abnormal—Fluorouracil—skin cancer	0.000123	0.00224	CcSEcCtD
Methoxsalen—Rash—Bleomycin—skin cancer	0.000121	0.00221	CcSEcCtD
Methoxsalen—Dermatitis—Bleomycin—skin cancer	0.000121	0.0022	CcSEcCtD
Methoxsalen—Hypersensitivity—Temozolomide—skin cancer	0.00012	0.00217	CcSEcCtD
Methoxsalen—Urticaria—Fluorouracil—skin cancer	0.000119	0.00216	CcSEcCtD
Methoxsalen—Body temperature increased—Fluorouracil—skin cancer	0.000118	0.00215	CcSEcCtD
Methoxsalen—Pruritus—Temozolomide—skin cancer	0.000115	0.00209	CcSEcCtD
Methoxsalen—Nausea—Bleomycin—skin cancer	0.000114	0.00208	CcSEcCtD
Methoxsalen—Rash—Dactinomycin—skin cancer	0.000113	0.00206	CcSEcCtD
Methoxsalen—Hypersensitivity—Fluorouracil—skin cancer	0.00011	0.002	CcSEcCtD
Methoxsalen—Oedema—Docetaxel—skin cancer	0.000108	0.00196	CcSEcCtD
Methoxsalen—Dizziness—Temozolomide—skin cancer	0.000107	0.00195	CcSEcCtD
Methoxsalen—Infection—Docetaxel—skin cancer	0.000107	0.00195	CcSEcCtD
Methoxsalen—Nausea—Dactinomycin—skin cancer	0.000107	0.00194	CcSEcCtD
Methoxsalen—Pruritus—Fluorouracil—skin cancer	0.000106	0.00192	CcSEcCtD
Methoxsalen—Skin disorder—Docetaxel—skin cancer	0.000105	0.00191	CcSEcCtD
Methoxsalen—Rash—Temozolomide—skin cancer	0.000102	0.00186	CcSEcCtD
Methoxsalen—Dermatitis—Temozolomide—skin cancer	0.000102	0.00186	CcSEcCtD
Methoxsalen—Headache—Temozolomide—skin cancer	0.000102	0.00185	CcSEcCtD
Methoxsalen—Hypotension—Docetaxel—skin cancer	0.000101	0.00183	CcSEcCtD
Methoxsalen—Dizziness—Fluorouracil—skin cancer	9.89e-05	0.0018	CcSEcCtD
Methoxsalen—Insomnia—Docetaxel—skin cancer	9.76e-05	0.00178	CcSEcCtD
Methoxsalen—Nausea—Temozolomide—skin cancer	9.64e-05	0.00175	CcSEcCtD
Methoxsalen—Dyspepsia—Docetaxel—skin cancer	9.5e-05	0.00173	CcSEcCtD
Methoxsalen—Rash—Fluorouracil—skin cancer	9.43e-05	0.00171	CcSEcCtD
Methoxsalen—Dermatitis—Fluorouracil—skin cancer	9.42e-05	0.00171	CcSEcCtD
Methoxsalen—Headache—Fluorouracil—skin cancer	9.37e-05	0.0017	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Docetaxel—skin cancer	9.32e-05	0.00169	CcSEcCtD
Methoxsalen—Feeling abnormal—Docetaxel—skin cancer	8.89e-05	0.00162	CcSEcCtD
Methoxsalen—Nausea—Fluorouracil—skin cancer	8.88e-05	0.00162	CcSEcCtD
Methoxsalen—Body temperature increased—Docetaxel—skin cancer	8.53e-05	0.00155	CcSEcCtD
Methoxsalen—Hypersensitivity—Docetaxel—skin cancer	7.95e-05	0.00145	CcSEcCtD
Methoxsalen—Pruritus—Docetaxel—skin cancer	7.64e-05	0.00139	CcSEcCtD
Methoxsalen—Dizziness—Docetaxel—skin cancer	7.14e-05	0.0013	CcSEcCtD
Methoxsalen—Rash—Docetaxel—skin cancer	6.81e-05	0.00124	CcSEcCtD
Methoxsalen—Dermatitis—Docetaxel—skin cancer	6.8e-05	0.00124	CcSEcCtD
Methoxsalen—Headache—Docetaxel—skin cancer	6.76e-05	0.00123	CcSEcCtD
Methoxsalen—Nausea—Docetaxel—skin cancer	6.41e-05	0.00117	CcSEcCtD
